Related references
Note: Only part of the references are listed.Comparison of the Efficacy and Safety of Oritavancin Front-Loaded Dosing Regimens to Daily Dosing: an Analysis of the SIMPLIFI Trial
Lala M. Dunbar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
A Call to Arms: The Imperative for Antimicrobial Stewardship
John G. Bartlett
CLINICAL INFECTIOUS DISEASES (2011)
Telemedicine: The Future of Outpatient Therapy?
Lawrence Eron
CLINICAL INFECTIOUS DISEASES (2010)
Meeting the Challenges of Methicillin-Resistant Staphylococcus aureus with Outpatient Parenteral Antimicrobial Therapy
Alan D. Tice et al.
CLINICAL INFECTIOUS DISEASES (2010)
Hospitalist to Home: Outpatient Parenteral Antimicrobial Therapy at an Academic Center
Hien H. Nguyen
CLINICAL INFECTIOUS DISEASES (2010)
The Unique Issues of Outpatient Parenteral Antimicrobial Therapy in Children and Adolescents
Mobeen H. Rathore
CLINICAL INFECTIOUS DISEASES (2010)
Serious Infections Caused by Methicillin-Resistant Staphylococcus aureus
Helen Boucher et al.
CLINICAL INFECTIOUS DISEASES (2010)
Complications Associated With Outpatient Parenteral Antibiotic Therapy in Children
Jennifer Le et al.
CLINICAL PEDIATRICS (2010)
New Lipoglycopeptides A Comparative Review of Dalbavancin, Oritavancin and Telavancin
George G. Zhanel et al.
DRUGS (2010)
Oritavancin: a novel lipoglycopeptide active against Gram-positive pathogens including multiresistant strains
Emilio Bouza et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Costs Attributable to Healthcare-Acquired Infection in Hospitalized Adults and a Comparison of Economic Methods
Rebecca R. Roberts et al.
MEDICAL CARE (2010)
Oritavancin Population Pharmacokinetics in Healthy Subjects and Patients with Complicated Skin and Skin Structure Infections or Bacteremia
Christopher M. Rubino et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium
Geoffrey A. McKay et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Therapeutic Monitoring of Vancomycin in Adults Summary of Consensus Recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists
Michael J. Rybak et al.
PHARMACOTHERAPY (2009)
Underresourced hospital infection control and prevention programs: Penny wise, pound foolish?
Deverick J. Anderson et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2007)
Impact of mandatory inpatient infectious disease consultation on outpatient parenteral antibiotic therapy
R Sharma et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2005)
Practice guidelines for outpatient parenteral antimicrobial therapy
AD Tice et al.
CLINICAL INFECTIOUS DISEASES (2004)
Outcomes of osteomyelitis among patients treated with outpatient parenteral antimicrobial therapy
AD Tice et al.
AMERICAN JOURNAL OF MEDICINE (2003)
Ambulatory antimicrobial use: the value of an outcomes registry
D Nathwani et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Share Paper
